The WHI Estrogen-Alone Trial—Do Things Look Any Better?

This publication has 13 references indexed in Scilit:

• National use of postmenopausal hormone therapy: annual trends and response to recent evidence
  Obstetrics & Gynecology, 2004
• Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women. The Women???s Health Initiative Memory Study: A Randomized, Controlled Trial
  Obstetrical & Gynecological Survey, 2003
• FDA Orders Estrogen Safety Warnings
  JAMA, 2003
• Postmenopausal Hormone Therapy and Risk of Stroke
  Circulation, 2001
• The Protective Effects of Estrogen on the Cardiovascular System
  New England Journal of Medicine, 1999
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
  Annual Review of Public Health, 1998
• Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor
  Annals of the New York Academy of Sciences, 1995
• Hormone replacement therapy and endometrial cancer risk: A meta-analysis
  Obstetrics & Gynecology, 1995
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
  Annals of Internal Medicine, 1992